Industry: Chemical & Material
Published Date: 2025-02-21
Pages: 101 Pages
Report ld: 4151800
Request Sample
Customized Report
Sanguinarine Market Size(US$)

CAGR 2025-2031
2.9%
Market Size,2031
USD 190
Million
Market Snapshot
Source: Secondary research, interviews with experts, and QYResearch analysis
The global market for Sanguinarine was estimated to be worth US$ 156 million in 2024 and is forecast to a readjusted size of US$ 190 million by 2031 with a CAGR of 2.9% during the forecast period 2025-2031.
Sanguinarine is an extract from Macleaya cordata.
Chemical is an important driver of this industry. Emerging economies, particularly in Asia and Latin America, are experiencing rapid industrialization, urbanization, and population growth. This drives the demand for bulk chemicals across various sectors, including construction, automotive, electronics, agriculture, and consumer goods. The rising middle class in these regions is also contributing to increased consumption of chemical products.
This report aims to provide a comprehensive presentation of the global market for Sanguinarine, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Sanguinarine by region & country, by Type, and by Application.
The Sanguinarine market size, estimations, and forecasts are provided in terms of sales volume (MT) and sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Sanguinarine.
MARKET SEGMENTATION
CHAPTER OUTLINE
Chapter 1: Introduces the report scope of the report, global total market size (value, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Sanguinarine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Sanguinarine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Sanguinarine in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
We identify regional market threats and growth prospects to guide your overseas layout.
We adjust product portfolios in line with local consumption habits.
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Market Overview
1.1 Sanguinarine Product Introduction
1.2 Global Sanguinarine Market Size Forecast
1.2.1 Global Sanguinarine Sales Value (2020-2031)
1.2.2 Global Sanguinarine Sales Volume (2020-2031)
1.2.3 Global Sanguinarine Sales Price (2020-2031)
1.3 Sanguinarine Market Trends & Drivers
1.3.1 Sanguinarine Industry Trends
1.3.2 Sanguinarine Market Drivers & Opportunity
1.3.3 Sanguinarine Market Challenges
1.3.4 Sanguinarine Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Sanguinarine Players Revenue Ranking (2024)
2.2 Global Sanguinarine Revenue by Company (2020-2025)
2.3 Global Sanguinarine Players Sales Volume Ranking (2024)
2.4 Global Sanguinarine Sales Volume by Company Players (2020-2025)
2.5 Global Sanguinarine Average Price by Company (2020-2025)
2.6 Key Manufacturers Sanguinarine Manufacturing Base and Headquarters
2.7 Key Manufacturers Sanguinarine Product Offered
2.8 Key Manufacturers Time to Begin Mass Production of Sanguinarine
2.9 Sanguinarine Market Competitive Analysis
2.9.1 Sanguinarine Market Concentration Rate (2020-2025)
2.9.2 Global 5 and 10 Largest Manufacturers by Sanguinarine Revenue in 2024
2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Sanguinarine as of 2024)
2.10 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 0.4
3.1.2 0.6
3.1.3 Others
3.2 Global Sanguinarine Sales Value by Type
3.2.1 Global Sanguinarine Sales Value by Type (2020 VS 2024 VS 2031)
3.2.2 Global Sanguinarine Sales Value, by Type (2020-2031)
3.2.3 Global Sanguinarine Sales Value, by Type (%) (2020-2031)
3.3 Global Sanguinarine Sales Volume by Type
3.3.1 Global Sanguinarine Sales Volume by Type (2020 VS 2024 VS 2031)
3.3.2 Global Sanguinarine Sales Volume, by Type (2020-2031)
3.3.3 Global Sanguinarine Sales Volume, by Type (%) (2020-2031)
3.4 Global Sanguinarine Average Price by Type (2020-2031)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Pharmaceutical Ingredients
4.1.2 Cosmetics Ingredients
4.1.3 Feed Additives
4.1.4 Agricultural Insecticide
4.1.5 Oral Care Products
4.2 Global Sanguinarine Sales Value by Application
4.2.1 Global Sanguinarine Sales Value by Application (2020 VS 2024 VS 2031)
4.2.2 Global Sanguinarine Sales Value, by Application (2020-2031)
4.2.3 Global Sanguinarine Sales Value, by Application (%) (2020-2031)
4.3 Global Sanguinarine Sales Volume by Application
4.3.1 Global Sanguinarine Sales Volume by Application (2020 VS 2024 VS 2031)
4.3.2 Global Sanguinarine Sales Volume, by Application (2020-2031)
4.3.3 Global Sanguinarine Sales Volume, by Application (%) (2020-2031)
4.4 Global Sanguinarine Average Price by Application (2020-2031)
5 Segmentation by Region
5.1 Global Sanguinarine Sales Value by Region
5.1.1 Global Sanguinarine Sales Value by Region: 2020 VS 2024 VS 2031
5.1.2 Global Sanguinarine Sales Value by Region (2020-2025)
5.1.3 Global Sanguinarine Sales Value by Region (2026-2031)
5.1.4 Global Sanguinarine Sales Value by Region (%), (2020-2031)
5.2 Global Sanguinarine Sales Volume by Region
5.2.1 Global Sanguinarine Sales Volume by Region: 2020 VS 2024 VS 2031
5.2.2 Global Sanguinarine Sales Volume by Region (2020-2025)
5.2.3 Global Sanguinarine Sales Volume by Region (2026-2031)
5.2.4 Global Sanguinarine Sales Volume by Region (%), (2020-2031)
5.3 Global Sanguinarine Average Price by Region (2020-2031)
5.4 North America
5.4.1 North America Sanguinarine Sales Value, 2020-2031
5.4.2 North America Sanguinarine Sales Value by Country (%), 2024 VS 2031
5.5 Europe
5.5.1 Europe Sanguinarine Sales Value, 2020-2031
5.5.2 Europe Sanguinarine Sales Value by Country (%), 2024 VS 2031
5.6 Asia Pacific
5.6.1 Asia Pacific Sanguinarine Sales Value, 2020-2031
5.6.2 Asia Pacific Sanguinarine Sales Value by Region (%), 2024 VS 2031
5.7 South America
5.7.1 South America Sanguinarine Sales Value, 2020-2031
5.7.2 South America Sanguinarine Sales Value by Country (%), 2024 VS 2031
5.8 Middle East & Africa
5.8.1 Middle East & Africa Sanguinarine Sales Value, 2020-2031
5.8.2 Middle East & Africa Sanguinarine Sales Value by Country (%), 2024 VS 2031
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Sanguinarine Sales Value Growth Trends, 2020 VS 2024 VS 2031
6.2 Key Countries/Regions Sanguinarine Sales Value
6.2.1 Key Countries/Regions Sanguinarine Sales Value, 2020-2031
6.2.2 Key Countries/Regions Sanguinarine Sales Volume, 2020-2031
6.3 United States
6.3.1 United States Sanguinarine Sales Value, 2020-2031
6.3.2 United States Sanguinarine Sales Value by Type (%), 2024 VS 2031
6.3.3 United States Sanguinarine Sales Value by Application, 2024 VS 2031
6.4 Europe
6.4.1 Europe Sanguinarine Sales Value, 2020-2031
6.4.2 Europe Sanguinarine Sales Value by Type (%), 2024 VS 2031
6.4.3 Europe Sanguinarine Sales Value by Application, 2024 VS 2031
6.5 China
6.5.1 China Sanguinarine Sales Value, 2020-2031
6.5.2 China Sanguinarine Sales Value by Type (%), 2024 VS 2031
6.5.3 China Sanguinarine Sales Value by Application, 2024 VS 2031
6.6 Japan
6.6.1 Japan Sanguinarine Sales Value, 2020-2031
6.6.2 Japan Sanguinarine Sales Value by Type (%), 2024 VS 2031
6.6.3 Japan Sanguinarine Sales Value by Application, 2024 VS 2031
6.7 South Korea
6.7.1 South Korea Sanguinarine Sales Value, 2020-2031
6.7.2 South Korea Sanguinarine Sales Value by Type (%), 2024 VS 2031
6.7.3 South Korea Sanguinarine Sales Value by Application, 2024 VS 2031
6.8 Southeast Asia
6.8.1 Southeast Asia Sanguinarine Sales Value, 2020-2031
6.8.2 Southeast Asia Sanguinarine Sales Value by Type (%), 2024 VS 2031
6.8.3 Southeast Asia Sanguinarine Sales Value by Application, 2024 VS 2031
6.9 India
6.9.1 India Sanguinarine Sales Value, 2020-2031
6.9.2 India Sanguinarine Sales Value by Type (%), 2024 VS 2031
6.9.3 India Sanguinarine Sales Value by Application, 2024 VS 2031
7 Company Profiles
7.1 Shaanxi Guanjie Technology
7.1.1 Shaanxi Guanjie Technology Company Information
7.1.2 Shaanxi Guanjie Technology Introduction and Business Overview
7.1.3 Shaanxi Guanjie Technology Sanguinarine Sales, Revenue, Price and Gross Margin (2020-2025)
7.1.4 Shaanxi Guanjie Technology Sanguinarine Product Offerings
7.1.5 Shaanxi Guanjie Technology Recent Development
7.2 Xi'an Lyphar Biotech
7.2.1 Xi'an Lyphar Biotech Company Information
7.2.2 Xi'an Lyphar Biotech Introduction and Business Overview
7.2.3 Xi'an Lyphar Biotech Sanguinarine Sales, Revenue, Price and Gross Margin (2020-2025)
7.2.4 Xi'an Lyphar Biotech Sanguinarine Product Offerings
7.2.5 Xi'an Lyphar Biotech Recent Development
7.3 Hunan MT Health
7.3.1 Hunan MT Health Company Information
7.3.2 Hunan MT Health Introduction and Business Overview
7.3.3 Hunan MT Health Sanguinarine Sales, Revenue, Price and Gross Margin (2020-2025)
7.3.4 Hunan MT Health Sanguinarine Product Offerings
7.3.5 Hunan MT Health Recent Development
7.4 Lisi (Xian) Bio-Tech
7.4.1 Lisi (Xian) Bio-Tech Company Information
7.4.2 Lisi (Xian) Bio-Tech Introduction and Business Overview
7.4.3 Lisi (Xian) Bio-Tech Sanguinarine Sales, Revenue, Price and Gross Margin (2020-2025)
7.4.4 Lisi (Xian) Bio-Tech Sanguinarine Product Offerings
7.4.5 Lisi (Xian) Bio-Tech Recent Development
7.5 Shaanxi Fuheng (FH) Biotechnology
7.5.1 Shaanxi Fuheng (FH) Biotechnology Company Information
7.5.2 Shaanxi Fuheng (FH) Biotechnology Introduction and Business Overview
7.5.3 Shaanxi Fuheng (FH) Biotechnology Sanguinarine Sales, Revenue, Price and Gross Margin (2020-2025)
7.5.4 Shaanxi Fuheng (FH) Biotechnology Sanguinarine Product Offerings
7.5.5 Shaanxi Fuheng (FH) Biotechnology Recent Development
7.6 Xian Biof Bio-Technology
7.6.1 Xian Biof Bio-Technology Company Information
7.6.2 Xian Biof Bio-Technology Introduction and Business Overview
7.6.3 Xian Biof Bio-Technology Sanguinarine Sales, Revenue, Price and Gross Margin (2020-2025)
7.6.4 Xian Biof Bio-Technology Sanguinarine Product Offerings
7.6.5 Xian Biof Bio-Technology Recent Development
7.7 Xian Kono Chem
7.7.1 Xian Kono Chem Company Information
7.7.2 Xian Kono Chem Introduction and Business Overview
7.7.3 Xian Kono Chem Sanguinarine Sales, Revenue, Price and Gross Margin (2020-2025)
7.7.4 Xian Kono Chem Sanguinarine Product Offerings
7.7.5 Xian Kono Chem Recent Development
8 Industry Chain Analysis
8.1 Sanguinarine Industrial Chain
8.2 Sanguinarine Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Sanguinarine Sales Model
8.5.2 Sales Channel
8.5.3 Sanguinarine Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.1.1 Research Programs/Design
10.1.1.2 Market Size Estimation
10.1.1.3 Market Breakdown and Data Triangulation
10.1.2 Data Source
10.1.2.1 Secondary Sources
10.1.2.2 Primary Sources
10.2 Author Details
10.3 Disclaimer
TABLE OF FIGURES
List of Tables
List of Figures
KEY QUESTIONS ADDRESSED BY THE REPORT
Related Reports
The global market for Sanguinarine was estimated to be worth US$ 160 million in 2025 and is projected to reach US$ 195 million, growing at a CAGR of 2.9% from 2026 to 2032.
Published Date: 2026-07-09
Pages: 127
USD 3950.00
(Single User License)
The global Sanguinarine market was valued at US$ 160 million in 2025 and is anticipated to reach US$ 195 million by 2032, at a CAGR of 2.9% from 2026 to 2032.
Published Date: 2026-04-25
Pages: 134
USD 2900.00
(Single User License)
The global Sanguinarine market is projected to grow from US$ 156 million in 2024 to US$ 190 million by 2031, at a CAGR of 2.9% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-10-25
Pages: 133
USD 4900.00
(Single User License)
The global Sanguinarine market size was US$ 156 million in 2024 and is forecast to a readjusted size of US$ 190 million by 2031 with a CAGR of 2.9% during the forecast period 2025-2031.
Published Date: 2025-02-21
Pages: 78
USD 4250.00
(Single User License)
The global market for Sanguinarine was valued at US$ 156 million in the year 2024 and is projected to reach a revised size of US$ 190 million by 2031, growing at a CAGR of 2.9% during the forecast period.
Published Date: 2025-02-21
Pages: 92
USD 2900.00
(Single User License)
Sanguinarine is an extract from Macleaya cordata.
Published Date: 2024-04-07
Pages: 92
USD 4900.00
(Single User License)
Sanguinarine is an extract from Macleaya cordata.
Published Date: 2024-01-10
Pages: 91
USD 2900.00
(Single User License)
The global market for Sanguinarine was estimated to be worth US$ 160 million in 2025 and is projected to reach US$ 195 million, growing at a CAGR of 2.9% from 2026 to 2032.
Published: 2026-07-09
Pages: 127
The global Sanguinarine market was valued at US$ 160 million in 2025 and is anticipated to reach US$ 195 million by 2032, at a CAGR of 2.9% from 2026 to 2032.
Published: 2026-04-25
Pages: 134
The global Sanguinarine market is projected to grow from US$ 156 million in 2024 to US$ 190 million by 2031, at a CAGR of 2.9% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-10-25
Pages: 133
The global Sanguinarine market size was US$ 156 million in 2024 and is forecast to a readjusted size of US$ 190 million by 2031 with a CAGR of 2.9% during the forecast period 2025-2031.
Published: 2025-02-21
Pages: 78
The global market for Sanguinarine was valued at US$ 156 million in the year 2024 and is projected to reach a revised size of US$ 190 million by 2031, growing at a CAGR of 2.9% during the forecast period.
Published: 2025-02-21
Pages: 92
Sanguinarine is an extract from Macleaya cordata.
Published: 2024-04-07
Pages: 92
Sanguinarine is an extract from Macleaya cordata.
Published: 2024-01-10
Pages: 91
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now